ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,433Medicare Part D Prescriptions Filled, Including Refills

Rank: 54 out of 1290

$679K Total Retail Price of All Prescriptions

Rank: 115 out of 1290

353 Patients Receiving at Least One Drug in Part D
75%Patients 65 Years and Older
85% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

3% of this provider’s 353 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 8,999 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $94 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
OMEPRAZOLE 438 365 1 2
AMLODIPINE BESYLATE 422 355 2 3
LOSARTAN POTASSIUM 401 326 3 19
LEVOTHYROXINE SODIUM 400 285 4 4
SIMVASTATIN 382 330 5 1
METFORMIN HCL 376 272 6 10
HYDROCHLOROTHIAZIDE 360 306 7 20
METOPROLOL SUCCINATE 266 235 8 14
FUROSEMIDE 252 219 9 9
LISINOPRIL 246 168 10 5
PRAVASTATIN SODIUM 234 179 11 42
ZOLPIDEM TARTRATE 229 173 12 15
ALENDRONATE SODIUM 227 201 13 39
METOPROLOL TARTRATE 213 177 14 7
ATENOLOL 190 136 15 18
RANITIDINE HCL 171 117 16 49
CARVEDILOL 167 140 17 12
CRESTOR 141 90 18 17
AMITRIPTYLINE HCL 129 99 R 19 97
FLUTICASONE PROPIONATE 128 91 20 26
GLIMEPIRIDE 127 78 21 57
JANUVIA 125 99 22 82
GABAPENTIN 121 87 23 8
ALLOPURINOL 111 92 24 60
DIOVAN HCT 107 95 25 112
DIOVAN 106 95 26 53
PROAIR HFA 102 72 27 73
WARFARIN SODIUM 99 98 28 22
LANSOPRAZOLE 98 91 29 181
SERTRALINE HCL 91 58 30 36
POTASSIUM CHLORIDE 90 79 31 35
ATORVASTATIN CALCIUM 85 84 32 23
GLIPIZIDE 83 65 33 81
NEXIUM 83 77 33 34
ONGLYZA 81 58 35 263
JANUMET 76 55 36 217
CLONIDINE HCL 76 69 36 66
CLOTRIMAZOLE-BETAMETHASONE 73 50 38 153
CLOPIDOGREL 71 54 39 24
LEVEMIR FLEXPEN 70 48 40 172
ACTONEL 69 68 41 207
SINGULAIR 68 51 42 85
ENALAPRIL MALEATE 67 61 43 62
LANTUS SOLOSTAR 65 56 44 88
PEN NEEDLE 63 49 45 72
LIDODERM 62 37 46 113
ISOSORBIDE MONONITRATE ER 62 44 46 58
PENTOXIFYLLINE 60 57 48 251
LISINOPRIL-HYDROCHLOROTHIAZIDE 58 57 49 92
ADVAIR DISKUS 57 37 50 37
PLAVIX 55 54 51 32
METFORMIN HCL ER 53 50 52 135
INSULIN SYRINGE 53 46 52 76
FLUOXETINE HCL 53 36 52 79
DONEPEZIL HCL 52 42 55 13
DIGOXIN 50 50 56 51
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.